Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 822.03B | 744.91B | 906.88B | 985.74B | 1.06T | 1.09T |
Gross Profit | 892.61B | 916.62B | 78.49B | 985.74B | 1.06T | 1.09T |
EBITDA | 198.35B | 207.86B | 166.21B | 123.40B | 214.40B | 282.62B |
Net Income | 116.91B | 126.61B | 85.67B | 83.77B | 101.62B | 143.10B |
Balance Sheet | ||||||
Total Assets | 13.18T | 12.96T | 11.58T | 11.14T | 10.14T | 9.53T |
Cash, Cash Equivalents and Short-Term Investments | 1.02T | 950.37B | 797.92B | 746.52B | 630.51B | 597.30B |
Total Debt | 1.30T | 1.40T | 1.49T | 1.48T | 1.59T | 1.42T |
Total Liabilities | 11.84T | 11.65T | 10.35T | 9.96T | 9.06T | 8.54T |
Stockholders Equity | 939.73B | 928.60B | 899.01B | 858.67B | 812.40B | 762.56B |
Cash Flow | ||||||
Free Cash Flow | 543.72B | 375.80B | 352.59B | 477.03B | 77.93B | 302.08B |
Operating Cash Flow | 342.66B | 382.47B | 360.40B | 485.90B | 90.12B | 312.07B |
Investing Cash Flow | -558.87B | -416.25B | -104.00B | -224.05B | 27.93B | -447.14B |
Financing Cash Flow | -39.40B | 30.95B | -222.06B | -230.66B | -136.41B | 260.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $945.21B | 7.11 | 50.52% | ― | ― | ||
78 Outperform | HK$372.91B | 5.39 | 17.85% | 4.55% | 4.62% | 81.63% | |
78 Outperform | $720.23B | 14.03 | 16.75% | 3.87% | 7.04% | 88.41% | |
75 Outperform | HK$183.32B | 4.70 | 26.08% | 5.05% | -43.77% | ― | |
75 Outperform | $1.04T | 4.56 | 22.83% | 2.63% | 5.96% | 124.20% | |
70 Outperform | $361.65B | 5.84 | 16.47% | 4.15% | 11.99% | 54.60% | |
58 Neutral | HK$91.09B | 5.21 | -3.21% | 5.20% | 7.36% | -55.21% |